Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Wasserman

Showing results (31-40 of 98) with videos related to

Pageof 10
Sort By:
Journal of Clinical Immunology|February 26, 2017
Case StudiesRalph S Shapiro, Richard L Wasserman, Vincent Bonagura, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 13, 2021
Exploiting nut cross-reactivity to facilitate real-world treatment of tree nut allergyRichard L Wasserman, Hugh H Windom, Daria Lie, et al.
Food Chemistry|March 14, 2015
Treatment with oleic acid reduces IgE binding to peanut and cashew allergensSi-Yin Chung, Christopher P Mattison, Shawndrika Reed, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2016
20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiencyRichard L Wasserman, Mark R Stein, M Elizabeth M Younger, et al.
The Journal of Allergy and Clinical Immunology|November 3, 2010
Office-based oral immunotherapy for food allergy is safe and effectiveRichard L Wasserman, Robert W Sugerman, Nana Mireku-Akomeah, et al.
Journal of Clinical Immunology|May 2, 2018
Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical TrialsMark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Journal of Clinical Immunology|February 5, 2017
Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin TherapyRichard L Wasserman, Diane Ito, Yan Xiong, et al.
Journal of Clinical Immunology|July 12, 2017
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical TrialsMark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2018
Measurement of exhaled nitric oxide in young childrenKathleen Rickard, Margot MacDonald-Berko, Robert Anolik, et al.
Immunotherapy|October 10, 2019
Manufacturing process optimization of ADMA Biologics' intravenous immunoglobulin products, BIVIGAM<sup>®</sup> and ASCENIV™Richard L Wasserman, Daniel Garcia, Benjamin N Greener, et al.
Pageof 10

Showing results (31-40 of 98) with videos related to

Sort By:
Pageof 10
Journal of Clinical Immunology|February 26, 2017
Case StudiesRalph S Shapiro, Richard L Wasserman, Vincent Bonagura, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 13, 2021
Exploiting nut cross-reactivity to facilitate real-world treatment of tree nut allergyRichard L Wasserman, Hugh H Windom, Daria Lie, et al.
Food Chemistry|March 14, 2015
Treatment with oleic acid reduces IgE binding to peanut and cashew allergensSi-Yin Chung, Christopher P Mattison, Shawndrika Reed, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 30, 2016
20% subcutaneous immunoglobulin dosed biweekly for primary immunodeficiencyRichard L Wasserman, Mark R Stein, M Elizabeth M Younger, et al.
The Journal of Allergy and Clinical Immunology|November 3, 2010
Office-based oral immunotherapy for food allergy is safe and effectiveRichard L Wasserman, Robert W Sugerman, Nana Mireku-Akomeah, et al.
Journal of Clinical Immunology|May 2, 2018
Correction to: Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical TrialsMark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Journal of Clinical Immunology|February 5, 2017
Impact of Site of Care on Infection Rates Among Patients with Primary Immunodeficiency Diseases Receiving Intravenous Immunoglobulin TherapyRichard L Wasserman, Diane Ito, Yan Xiong, et al.
Journal of Clinical Immunology|July 12, 2017
Assessment of Local Adverse Reactions to Subcutaneous Immunoglobulin (SCIG) in Clinical TrialsMark Ballow, Richard L Wasserman, Stephen Jolles, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|November 27, 2018
Measurement of exhaled nitric oxide in young childrenKathleen Rickard, Margot MacDonald-Berko, Robert Anolik, et al.
Immunotherapy|October 10, 2019
Manufacturing process optimization of ADMA Biologics' intravenous immunoglobulin products, BIVIGAM<sup>®</sup> and ASCENIV™Richard L Wasserman, Daniel Garcia, Benjamin N Greener, et al.
Pageof 10